SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 1.18 |
| Enterprise Value ($M) | -0.70 |
| Book Value ($M) | 1.65 |
| Book Value / Share | 2.37 |
| Price / Book | 0.71 |
| NCAV ($M) | 1.33 |
| NCAV / Share | 1.91 |
| Price / NCAV | 0.89 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -8.27 |
| Return on Assets (ROA) | -2.89 |
| Return on Equity (ROE) | -9.10 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.58 |
| Current Ratio | 1.58 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 3.61 |
| Assets | 3.94 |
| Liabilities | 2.28 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Anson Funds Management LP | 9.90 | ||
| 13G | Sabby Management, Llc | 9.90 | ||
| 13G/A | 3i, LP | 0.00 | -100.00 | |
| 13D | Fitzgerald Thomas A | 5.50 | ||
| 13G/A | Medarova Zdravka | 0.40 | -93.25 | |
| 13G/A | Tang Capital Partners Lp | 0.00 | -100.00 | |
| 13G/A | Lind Global Fund II LP | 0.10 | -98.95 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 261,403 | 810,816 | 32.24 | |
| 315,022 | 992,404 | 31.74 | |
| 475,833 | 1,647,944 | 28.87 | |
| 125,868 | 396,740 | 31.73 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| RGC – Regencell Bioscience Holdings Limited | RGLS – Regulus Therapeutics Inc. |
| RMTI – Rockwell Medical, Inc. | RNTX – Rein Therapeutics Inc. |
| RNXT – RenovoRx, Inc. |
Financial data and stock pages provided by
Fintel.io